Marinus - Ownership and Business Overview

Life ScienceCompany

Marinus Ownership

Who owns Marinus?

.

Marinus Business Overview

Where is Marinus headquartered?

Marinus is headquartered in Radnor, Pennsylvania.

What is Marinus’ revenue?

Marinus disclosed revenue of 31M USD for 2023 and 25M USD for 2022.

What sector is Marinus in?

Marinus is a life science company.

Life Science M&A Summary in

Join Mergr to view all 0 acquisitions of life science companies in , including .

Marinus

Marinus Pharmaceuticals, Inc.

5 Radnor Corporate Center, 100 Matsonford Rd, Suite 500,
Radnor, Pennsylvania 19087
United States,
(484) 801-4670
www.marinuspharma.com

Marinus is a commercial-stage pharmaceutical company dedicated to the development of innovative therapeutics for seizure disorders. The Company’s product, ZTALMY (ganaxolone) oral suspension CV, is an FDA-approved prescription medication introduced in the U.S. in 2022. Marinus is based in Radnor, Pennsylvania.


 Subscribe to unlock this and 209,632
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.